Polyunsaturated fatty acids confer cryoresistance on megakaryocytes generated from cord blood and also enhance megakaryocyte production from cryopreserved cord blood cells

Cytotherapy

Volumn 14, Issue 3, 2012, Pages 366-380

  Shabrani, Namrata C ^a   Khan, Nikhat Firdaus Q ^a   Kale, Vaijayanti P ^a   Limaye, Lalita S ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Arachidonic acid; Cryopreservation; Docosahexanoic acid; Megakaryocytes

Indexed keywords

ARACHIDONIC ACID; CATALASE; CD34 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; DIMETHYL SULFOXIDE; DNA; DOCOSAHEXAENOIC ACID; GLUTATHIONE PEROXIDASE 1; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; STEM CELL FACTOR; THROMBOPOIETIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; COLD STRESS; COLD TOLERANCE; COLONY FORMING UNIT; CONTROLLED STUDY; CORD BLOOD STEM CELL; CRYOPRESERVATION; CULTURE MEDIUM; DNA CONTENT; ENGRAFTMENT; FATTY ACID METABOLISM; FREEZE THAWING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEGAKARYOCYTE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; UMBILICAL CORD BLOOD; UPREGULATION;

EID: 84856847228     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.649186     Document Type: Article

References (58)

1. Liao Y, Geyer MB, Yang AJ, Cairo MS. Cord blood transplantation and stem cell regenerative potential. Exp Hematol. 2011;39:393-412.
2. + cells after allogeneic bone marrow transplantation. J Hematother Stem Cell Res. 2002;11:321-6. (Pubitemid 34309525)
3. Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 1997; 89:2679-88. (Pubitemid 27172552)
4. Decaudin D, Vantelon JM, Bourhis JH, Farace F, Bonnet ML, Guillier M, et al. Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma. Bone Marrow Transplant. 2004; 34:1089-93. (Pubitemid 40028843)
5. Drayer AL, Smit Sibinga CT, Esselink MT, de Wolf JT, Vellenga E. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation. Ann Hematol. 2002;81:192-7. (Pubitemid 36067606)
6. Scheding S, Bergmannn M, Rathke G, Vogel W, Brugger W, Kanz L. Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy. Haemato-logica. 2004;89:630-1. (Pubitemid 38691262)
7. Chen TW, Hwang SM, Chu IM, Hsu SC, Hsieh TB, Yao CL. Characterization and transplantation of induced megakaryo-cytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure. Exp Hematol. 2009; 37:1330-9.
8. Ratajczak MZ, Ratajczak J, Machalinski B, Mck R, Gewirtz AM. In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia. Blood. 1998;91:353-9. (Pubitemid 28018765)
9. Tijssen MR, van Hennik PB, di Summa F, Zwaginga JJ, van der Schoot CE, Voermans C. Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice. Leukemia. 2008;22:203-8.
10. Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol. 2003;31:413-20. (Pubitemid 36579367)
11. Berthier R, Valiron O, Troesch A, Clemancey-Marcille G, Schweitzer A, Hollard D. Cryopreservation of human meg-akaryocytic progenitor cells (CFU-MK): influence of culture conditions. Cryobiology. 1989;26:265-72. (Pubitemid 19152867)
12. Pick M, Eldor A, Grisaru D, Zander AR, Shenhav M, Deut-sch VR. Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. A potential source of megakaryocytes for transplantation. Exp Hematol. 2002; 30:1079-87. (Pubitemid 35286624)
13. Sasayama N, Kashiwakura I, Tokushima Y, Wada S, Murakami M, Hayase Y, et al. Expansion of megakaryocyte progenitors from cryopreserved leukocyte concentrates of human placental and umbilical cord blood in short-term liquid culture. Cytotherapy. 2001;3:117-26. (Pubitemid 32466096)
14. Xu Y, Kashiwakura I, Takahashi TA. High sensitivity of meg-akaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses during cryopreservation. Bone Marrow Transplant. 2004;34:537-43. (Pubitemid 39264046)
15. Lazzari L, Lucchi S, Montemurro T, Porretti L, Lopa R, Rebulla P, et al. Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood. Bone Marrow Transplant. 2001;28:693-8. (Pubitemid 33014604)
16. Moezzi L, Pourfathollah AA, Alimoghaddam K, Soleimani M, Ardjmand AR. The effect of cryopreservation on clono-genic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplant Proc. 2005;37: 4500-3.
17. Gentry T, Deibert E, Foster SJ, Haley R, Kurtzberg J, Balber AE. Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood. Cytotherapy. 2007;9:569-76. (Pubitemid 47457009)
18. Mwamtemi HH, Higuchi T, Sawai N, Hidaka E, Koike K. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow. Transplantation. 2000;69: 1645-54.
19. Eritsland J. Safety considerations of polyunsaturated fatty acids. Am J Clin Nutr. 2000;71(Suppl 1):197S-201S. (Pubitemid 30046116)
20. Holub BJ. Clinical nutrition. IV. Omega-3 fatty acids in cardiovascular care. Can Med Assoc J. 2002;166:608-15. (Pubitemid 34251494)
21. De Lorgeril M. Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases. Subcell Biochem. 2007;42:283-97.
22. Adkins Y, Kelley DS. Mechanisms underlying the cardiopro-tective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010;21:781-92.
23. Simopoulos AP. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr. 2008;17 (Suppl 1):131-4.
24. Davis-Brunoand K, Tassinari MS. Essential fatty acid supplementation of DHA and ARA and effects on neu-rodevelopment across animal species: a review of the literature. Birth Defects Res B Dev Reprod Toxicol. 2011;92: 240-50.
25. Siddiqui NF, Shabrani NC, Kale VP, Limaye LS. Enhanced generation of megakaryocytes from umbilical cord blood-derived CD34(+) cells expanded in the presence of two nutraceuticals, docosahexanoic acid and arachidonic acid, as supplements to the cytokine containing medium. Cytotherapy. 2011;13:114-28.
26. Sasnoor LM, Kale VP, Limaye LS. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J Hematother Stem Cell Res. 2003;12:553-64. (Pubitemid 37305567)
27. Limaye LS, Kale VP. Cryopreservation of human haematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium. J Haema-tother Stem Cell Res. 2001;10:709-18. (Pubitemid 32988622)
28. + cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol. 2008;36:244-52.
29. + cells. Biochem Biophys Res Com-mun. 2009;378:112-17.
30. O'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, et al. 15-deoxydelta12,14-PGJ2 enhances platelet production from megakaryocytes. Blood. 2008;112: 4051-60.
31. Shirvaikar N, Reca R, Jalili A, Marquez-Curtis L, Lee SF, Ratajczak MZ, et al. CFUmegakaryocytic progenitors expanded ex vivo from cord blood maintain their in vitro homing potential and express matrix metalloproteinases. Cytotherapy. 2008;10:182-92.
32. De Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev. 2005;14: 415-24. (Pubitemid 41243705)
33. Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, Li CK, Yuen PM. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant. 2001;27:1075-80. (Pubitemid 32591192)
34. Schipper LF, Brand A, Reniers N, Melief CJ, Willemze R, Fibbe WE. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol. 2003;31:324-30. (Pubitemid 36407609)
35. + stem cells derived from cord blood, peripheral blood and bone marrow from adults and children. Exp Hematol. 2000;28:1054-61.
36. Tao H, Gaudry L, Rice A, Chong B. Megakaryopoiesis: cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol. 1999;27:293-301. (Pubitemid 29131741)
37. Sahler J, Bernard JJ, Spinelli SL, Blumberg N, Phipps RP. The feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-?B inhibition. Thromb Res. 2011;127:426-34.
38. Petronelli A, Pelosi E, Santoro S, Saulle E, Cerio AM, Mariani G, et al. CDDO-Im is a stimulator of megakaryocytic differentiation. Leuk Res. 2011;35:534-44.
39. + cells using a short two-phase culture system. J Immunol Methods. 2008;332:82-91.
40. Kashiwakura I, Takahashi K, Monzen S, Nakamura T, Takagaki K. Ex vivo expansions of megakaryocytopoiesis from placental and umbilical cord blood CD34(+) cells in serum-free culture supplemented with proteoglycans extracted from the nasal cartilage of salmon heads and the nasal septum cartilage of whale. Life Sci. 2008;82:1023-31.
41. Kishore V, Eliason JF, Matthew HW. Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release. J Biomed Mater Res A. 2011; 96:682-92.
42. + cells. Stem Cells. 2006; 24:2877-87. (Pubitemid 46053024)
43. + cells are correlated with different levels of platelet release. Blood. 2002;99:888-97. (Pubitemid 34525550)
44. Reems JA, Pineault N, Sun S. In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev. 2010;24:33-43.
45. Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC. Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol. 2009;37: 101-10.
46. Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie. 2009;91: 791-5.
47. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009;81:187-91.
48. Stables MJ, Gilroy DW. Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res. 2011;50:35-51.
49. Hughes-Fulford M, Tjandrawinata RR, Li CF, Sayyah S. Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. Carcinogenesis. 2005;26:1520-6. (Pubitemid 41236045)
50. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA. 2003;100:1751-6. (Pubitemid 36254520)
51. Chan AC, Wagner M, Kennedy C, Chen E, Lanuville O, Mezl VA, et al. Vitamin E up-regulates arachidonic acid release and phospholipase A2 in megakaryocytes. Mol Cell Biochem. 1998;189:153-9. (Pubitemid 28556560)
52. Sergeeva M, Strokin M, Reiser G. Regulation of intracellular calcium levels by polyunsaturated fatty acids, arachidonic acid and docosahexaenoic acid, in astrocytes: possible involvement of phospholipase A2. Reprod Nutr Dev. 2005;45:633-46. (Pubitemid 41511886)
53. Franks DJ, Mroske C, Laneuville O. A fluorescence microscopy method for quantifying levels of prostaglandin endoperoxide H synthase-1 and CD-41 in MEG-01 cells. Biol Proced Online. 2001;3:54-63. (Pubitemid 33807182)
54. Mroske C, Plant MH, Franks DJ, Laneuville O. Characterization of prostaglandin endoperoxide H synthase-1 enzyme expression during differentiation of the megakaryocytic cell line MEG-01. Exp Hematol. 2000;28:411-21. (Pubitemid 30214153)
55. Tanaka N, Sato T, Fujita H, Morita I. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryo-cytopoiesis. Arterioscler Thromb Vasc Biol. 2004;24:607-12. (Pubitemid 38326160)
56. Rocca B, Secchiero P, Ciabattoni G, Ranelletti FO, Catani L, Guidotti L, et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci USA. 2002;99:7634-9. (Pubitemid 34568743)
57. Guillot N, Debard C, Calzada C, Vidal H, Lagarde M, Vericel E. Effects of docosahexaenoic acid on some megakaryocytic cell gene expression of some enzymes controlling prostanoid synthesis. Biochem Biophys Res Commun. 2008;372:924-8.
58. Miyazaki R, Ogata H, Iguchi T, Sogo S, Kushida T, Ito T, et al. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol. 2000;108: 602-9. (Pubitemid 30196259)